A carregar...
Hurdles to the Development of Effective HBV Immunotherapies and HCV Vaccines
Chronic infections with HBV and HCV continue to be major public health problems, with hundreds of millions of people infected worldwide; this is despite the availability of both an effective prophylactic HBV vaccine for more than 3 decades and potent direct antivirals for HBV and, more recently, HCV...
Na minha lista:
| Publicado no: | Pathog Immun |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Pathogens and Immunity
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5486412/ https://ncbi.nlm.nih.gov/pubmed/28664194 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.20411/pai.v2i1.201 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|